Literature DB >> 24955896

Mechanical ventilation augments bleomycin-induced epithelial-mesenchymal transition through the Src pathway.

Li-Fu Li1, Yung-Yang Liu2, Kuo-Chin Kao1, Chen-Te Wu3, Chih-Hao Chang4, Chen-Yiu Hung4, Cheng-Ta Yang1.   

Abstract

Mechanical ventilation used in patients with acute respiratory distress syndrome (ARDS) can damage pulmonary epithelial cells by producing inflammatory cytokines and depositing excess collagen. Src participates in plasminogen activator inhibitor-1 (PAI-1) and transforming growth factor-β1(TGF-β1) production during the fibroproliferative phase of ARDS, which involves a process of epithelial-mesenchymal transition (EMT). The mechanisms regulating interactions between mechanical ventilation and EMT are unclear. We hypothesized that EMT induced by high-tidal volume (VT) mechanical stretch-augmented lung inflammation occurs through upregulation of the Src pathway. Five days after administering bleomycin to simulate acute lung injury (ALI), male C57BL/6 mice, either wild-type or Src-deficient, aged 3 months, weighing between 25 and 30 g, were exposed to low-VT (6 ml/kg) or high-VT (30 ml/kg) mechanical ventilation with room air for 1-5 h. Nonventilated mice were used as control subjects. We observed that high-VT mechanical ventilation increased microvascular permeability, PAI-1 and TGF-β1 protein levels, Masson's trichrome staining, extracellular collagen levels, collagen gene expression, fibroblast accumulation, positive staining of α-smooth muscle actin and type I collagen, activation of Src signaling and epithelial apoptotic cell death in wild-type mice (P<0.05). Decreased staining of the epithelial marker, Zonula occludents-1, was also observed. Mechanical stretch-augmented EMT and epithelial apoptosis were attenuated in Src-deficient mice and pharmacological inhibition of Src activity by PP2 (P<0.05). Our data suggest that high-VT mechanical ventilation-augmented EMT after bleomycin-induced ALI partially depends on the Src pathway.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24955896     DOI: 10.1038/labinvest.2014.75

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  35 in total

Review 1.  Models and mechanisms of acute lung injury caused by direct insults.

Authors:  Lucy Kathleen Reiss; Ulrike Uhlig; Stefan Uhlig
Journal:  Eur J Cell Biol       Date:  2012-01-26       Impact factor: 4.492

2.  Alveolar epithelial cells express mesenchymal proteins in patients with idiopathic pulmonary fibrosis.

Authors:  Cecilia Marmai; Rachel E Sutherland; Kevin K Kim; Gregory M Dolganov; Xiaohui Fang; Sophia S Kim; Shuwei Jiang; Jeffery A Golden; Charles W Hoopes; Michael A Matthay; Harold A Chapman; Paul J Wolters
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-04-15       Impact factor: 5.464

3.  Suppression of plasminogen activator inhibitor-1 by RNA interference attenuates pulmonary fibrosis.

Authors:  Tadashi Senoo; Noboru Hattori; Takuya Tanimoto; Makoto Furonaka; Nobuhisa Ishikawa; Kazunori Fujitaka; Yoshinori Haruta; Hiroshi Murai; Akihito Yokoyama; Nobuoki Kohno
Journal:  Thorax       Date:  2010-04       Impact factor: 9.139

4.  Mechanical stress induces lung fibrosis by epithelial-mesenchymal transition.

Authors:  Nuria E Cabrera-Benítez; Matteo Parotto; Martin Post; Bing Han; Peter M Spieth; Wei-Erh Cheng; Francisco Valladares; Jesús Villar; Mingayo Liu; Masaaki Sato; Haibo Zhang; Arthur S Slutsky
Journal:  Crit Care Med       Date:  2012-02       Impact factor: 7.598

5.  Inhibition of the Src and Jak kinases protects against lipopolysaccharide-induced acute lung injury.

Authors:  Mariano Severgnini; Satoe Takahashi; Powen Tu; George Perides; Robert J Homer; Jhung W Jhung; Deepa Bhavsar; Brent H Cochran; Amy R Simon
Journal:  Am J Respir Crit Care Med       Date:  2005-01-21       Impact factor: 21.405

6.  Role of endoplasmic reticulum stress in epithelial-mesenchymal transition of alveolar epithelial cells: effects of misfolded surfactant protein.

Authors:  Qian Zhong; Beiyun Zhou; David K Ann; Parviz Minoo; Yixin Liu; Agnes Banfalvi; Manda S Krishnaveni; Mickael Dubourd; Lucas Demaio; Brigham C Willis; Kwang-Jin Kim; Roland M duBois; Edward D Crandall; Michael F Beers; Zea Borok
Journal:  Am J Respir Cell Mol Biol       Date:  2010-12-17       Impact factor: 6.914

7.  Effectiveness of rosiglitazone on bleomycin-induced lung fibrosis: Assessed by micro-computed tomography and pathologic scores.

Authors:  Gong Yong Jin; Se Mi Bok; Young Min Han; Myung Ja Chung; Kwon-Ha Yoon; So Ri Kim; Yong Chul Lee
Journal:  Eur J Radiol       Date:  2011-02-05       Impact factor: 3.528

8.  Alveolar fibrinolytic capacity suppressed by injurious mechanical ventilation.

Authors:  Peter Dahlem; Albert P Bos; Jack J Haitsma; Marcus J Schultz; Joost C M Meijers; Burkhard Lachmann
Journal:  Intensive Care Med       Date:  2005-03-08       Impact factor: 17.440

9.  Alveolar fibroblasts in acute lung injury: biological behaviour and clinical relevance.

Authors:  C Quesnel; L Nardelli; P Piednoir; V Leçon; J Marchal-Somme; S Lasocki; L Bouadma; I Philip; P Soler; B Crestani; M Dehoux
Journal:  Eur Respir J       Date:  2009-10-19       Impact factor: 16.671

10.  Pulmonary fibrosis correlates with outcome in adult respiratory distress syndrome. A study in mechanically ventilated patients.

Authors:  C Martin; L Papazian; M J Payan; P Saux; F Gouin
Journal:  Chest       Date:  1995-01       Impact factor: 9.410

View more
  7 in total

Review 1.  Inflammatory and Fibrinolytic System in Acute Respiratory Distress Syndrome.

Authors:  Mahesh Manjunath Gouda; Sadiya B Shaikh; Yashodhar Prabhakar Bhandary
Journal:  Lung       Date:  2018-08-18       Impact factor: 2.584

2.  Multi-omics data integration and network-based analysis drives a multiplex drug repurposing approach to a shortlist of candidate drugs against COVID-19.

Authors:  Marios Tomazou; Marilena M Bourdakou; George Minadakis; Margarita Zachariou; Anastasis Oulas; Evangelos Karatzas; Eleni M Loizidou; Andrea C Kakouri; Christiana C Christodoulou; Kyriaki Savva; Maria Zanti; Anna Onisiforou; Sotiroula Afxenti; Jan Richter; Christina G Christodoulou; Theodoros Kyprianou; George Kolios; Nikolas Dietis; George M Spyrou
Journal:  Brief Bioinform       Date:  2021-11-05       Impact factor: 11.622

3.  An in silico framework for integrating epidemiologic and genetic evidence with health care applications: ventilation-related pneumothorax as a case illustration.

Authors:  Yelizaveta Torosyan; Yuzhi Hu; Sarah Hoffman; Qianlai Luo; Bruce Carleton; Danica Marinac-Dabic
Journal:  J Am Med Inform Assoc       Date:  2016-04-23       Impact factor: 7.942

4.  Activation of Src-dependent Smad3 signaling mediates the neutrophilic inflammation and oxidative stress in hyperoxia-augmented ventilator-induced lung injury.

Authors:  Li-Fu Li; Chung-Shu Lee; Yung-Yang Liu; Chih-Hao Chang; Chang-Wei Lin; Li-Chung Chiu; Kuo-Chin Kao; Ning-Hung Chen; Cheng-Ta Yang
Journal:  Respir Res       Date:  2015-09-16

5.  Nintedanib reduces ventilation-augmented bleomycin-induced epithelial-mesenchymal transition and lung fibrosis through suppression of the Src pathway.

Authors:  Li-Fu Li; Kuo-Chin Kao; Yung-Yang Liu; Chang-Wei Lin; Ning-Hung Chen; Chung-Shu Lee; Chih-Wei Wang; Cheng-Ta Yang
Journal:  J Cell Mol Med       Date:  2017-06-09       Impact factor: 5.310

6.  Trichostatin A attenuates ventilation-augmented epithelial-mesenchymal transition in mice with bleomycin-induced acute lung injury by suppressing the Akt pathway.

Authors:  Li-Fu Li; Chung-Shu Lee; Chang-Wei Lin; Ning-Hung Chen; Li-Pang Chuang; Chen-Yiu Hung; Yung-Yang Liu
Journal:  PLoS One       Date:  2017-02-24       Impact factor: 3.240

7.  Airway basal cells show a dedifferentiated KRT17highPhenotype and promote fibrosis in idiopathic pulmonary fibrosis.

Authors:  Benedikt Jaeger; Jonas Christian Schupp; Linda Plappert; Oliver Terwolbeck; Nataliia Artysh; Gian Kayser; Peggy Engelhard; Taylor Sterling Adams; Robert Zweigerdt; Henning Kempf; Stefan Lienenklaus; Wiebke Garrels; Irina Nazarenko; Danny Jonigk; Malgorzata Wygrecka; Denise Klatt; Axel Schambach; Naftali Kaminski; Antje Prasse
Journal:  Nat Commun       Date:  2022-09-26       Impact factor: 17.694

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.